Biosimilars: From Science to Practice in Cancer Care – UCL

Access the course here: https://www.ucl.ac.uk/pharmacy/study/professional-development/biosimilars-science-practice-cancer-care

In this expert authored eLearning module, our team at UCL School of Pharmacy, collaborating with pharmacists at University College London and The Royal Marsden Hospital, will take you through the scientific knowledge needed in the adoption of biosimilar medicines.

Learning objectives

On completion of the eLearning module, you will be able to:

  • Demonstrate your understanding of the difference between biologic and chemical drugs.
  • Improve your understanding of biosimilars vs generics in terms of characteristics of structure and the clinical trials required.
  • Demonstrate knowledge of comparability studies and regulatory data.
  • Improve knowledge of practical aspects of adopting biosimilars – storage and stability differences.
  • Show understanding of patient considerations eg. revised consent, adverse reactions and patient information.
  • Improve confidence in handling clinician concerns prior to uptake.

Join this course

The course is free to access. Please click here to enrol. You will be taken to a webpage where you need to click ‘Select’. After this you will need to log in if you have a UCL Extend Account, or create a new account.

If you have any queries about the course please contact Pinkie Chambers at [email protected]

Follow the Twitter handle @UCLbiosimilar to join in with the discussion, ask questions and stay up to date with recent developments.

Latest News

By Mohammed Patel on 11th November 2026

UK BMT Pharmacists Group Educational Meeting – Friday 13th November 2026. Time:14:00 to 16:00

The next UK BMT Pharmacists Group Educational Meeting is on Friday 13th November, 2pm–4pm. The sessions include: Maintenance Therapy for AML After Allogeneic BMT with Dr Mili Shah, Consultant Haematologist,…

Read article
By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article
By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article